TetraPhase Pharmaceuticals to Present at Stifel Nicolaus 2012 Healthcare Conference

WATERTOWN, Mass.--(BUSINESS WIRE)--Tetraphase Pharmaceuticals, Inc., a clinical-stage life science company developing a portfolio of potent new antibiotics designed to be effective against dangerous, drug-resistant bacteria (including multidrug-resistant (MDR) gram-negative pathogens), today announced that Tetraphase President & Chief Executive Officer Guy Macdonald will present at the Stifel Nicolaus 2012 Healthcare Conference on Wednesday, September 5, 2012, at 3:50 p.m. Eastern time. The conference will take place at The Four Seasons Hotel in Boston, Massachusetts.

MORE ON THIS TOPIC